ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE WITH MONTHLY IBANDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
Ancuta, Codrina [1 ,2 ]
Ancuta, Eugen [3 ]
Iordache, Cristina [1 ]
Belibou, Codruta [4 ]
Chirieac, Rodica [1 ]
机构：
[1] Gr T Popa Univ Med & Pharm, Iasi, Romania
[2] European Ctr Translat Res, GT Popa Ctr Biomed Res, Iasi, Romania
[3] Cuza Voda Hosp, Res Dept, Iasi, Romania
[4] Rehabil Hosp, Res Dept, Iasi, Romania
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：308 / 309
页数：2
相关论文
共 50 条
  • [41] Health-related quality of life in established postmenopausal osteoporosis subject with and without prevalent vertebral fractures
    Salaffi, F.
    Stancati, A.
    Malavolta, N.
    Frigato, M.
    Gutierrez, M.
    Garofalo, J.
    Grassi, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 428 - 428
  • [42] Health-related quality of life and treatment of postmenopausal osteoporosis: Results from the HORIZON-PFT
    Sambrook, Philip N.
    Silverman, Stuart L.
    Cauley, Jane A.
    Recknor, Chris
    Olson, Melvin
    Su, Guoqin
    Boonen, Steven
    Black, Dennis
    Adachi, Jonathan D.
    BONE, 2011, 48 (06) : 1298 - 1304
  • [43] Monthly oral ibandronate is at least as effective as oral daily ibandronate in postmenopausal osteoporosis: 1-Year results from MOBILE.
    Miller, PD
    Drezner, HK
    Delmas, PD
    Stakkestad, JA
    Hughes, C
    Bonvoisin, B
    Reginster, JY
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S94 - S94
  • [44] Tri-monthly intravenous injections of ibandronate (2mg) for treatment of postmenopausal osteoporosis.
    Pecherstorfer, M
    Loho, N
    Mirzai, S
    Brenner, K
    Hoyle, N
    Felsenberg, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S406 - S406
  • [45] Tolerability of monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Recker, RR
    Silverman, SL
    Kendler, DL
    Dumont, E
    Hughes, BBC
    Reginster, JY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S293 - S294
  • [46] Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women
    Kung, Annie Wai-Chee
    Rachman, Ichramsjah A.
    Adam, John M. F.
    Roeshadi, Djoko
    Torralba, Tito
    Navarra, Sandra
    Gamilla, Zayda
    Canete, Arthur
    de la Rosa, Miles
    Tsai, KehSung
    Lin, Hsiao-Yi
    Soong, Yung Kuei
    Lan, Joung-Liang
    Hsu, Horng-Chaung
    Tu, Shih-Te
    Lin, Ruey-Mo
    Yuktanandana, Pongsak
    Songpatanasilp, Thawee
    Ngarmukos, Srihatach
    Soontrapa, Sugree
    Soontrapa, Suppasin
    Rojanasthien, Sattaya
    Luevitoonvechkij, Sirichai
    Leerapan, Taninnit
    Albert, Adelin
    Vanbelle, Sophie
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2009, 12 (03) : 216 - 224
  • [47] EFFICACY OF IBANDRONATE ON BONE PAIN IN POSTMENOPAUSAL OSTEOPOROSIS
    Marinchev, L.
    Nestorova, R.
    Rashkov, R.
    Kolarov, Z.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S754 - S754
  • [48] POSITIVE EFFECT OF PARENTERAL IBANDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS
    Mulic, S.
    Hajdarovic, A.
    Antic, D.
    Tulumovic, E.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S380 - S380
  • [49] EFFICIENCY AND SAFETY OF IBANDRONATE IN TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Gojkovic, F.
    Vasic, J.
    Elez, J.
    Vojinovic, V. Culafic
    Zvekic-Svorcan, J.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S169 - S169
  • [50] Intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis
    Thiebaud, D
    Kriegbaum, H
    Huss, H
    Christiansen, C
    Burckhardt, P
    OSTEOPOROSIS 1996, 1996, 1118 : 321 - 325
12345